Stryker (SYK) Cash from Investing Activities (2009 - 2026)
Stryker's (SYK) quarterly Cash from Investing Activities came in at -$639.0 million in Q2 2026, down 514.42% year-over-year from $154.2 million in Q2 2025, and down 245.41% quarter-over-quarter from -$185.0 million in Q1 2026.
Analysis
Stryker (SYK) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Stryker (SYK) has reported Cash from Investing Activities for 18 consecutive years, with -$639.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 514.42% year-over-year to -$639.0 million in Q2 2026; TTM through Jun 2026 was -$1.5 billion, a 78.41% increase from a year earlier, with the FY2025 full-year figure at -$4.9 billion, down 62.2% from the prior year.
- Cash from Investing Activities was -$639.0 million for Q2 2026 at Stryker, down from -$185.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $72.0 million in Q3 2022 and troughed at -$4.1 billion in Q1 2025.
- A 5-year average of -$698.7 million and a median of -$244.0 million in 2024 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 129.15% in 2022, down 2693.75% in 2022.
- Over 5 years, Cash from Investing Activities stood at -$162.0 million in 2022, then advanced by 6.17% to -$152.0 million in 2023, then plunged by 99.34% to -$303.0 million in 2024, then retreated by 0.66% to -$305.0 million in 2025, then tumbled by 109.51% to -$639.0 million in 2026.
- The last three Cash from Investing Activities figures came in at -$639.0 million (Q2 2026), -$185.0 million (Q1 2026), and -$305.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | -190.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -639.00 Mn |
| Mar 31, 2026 | -185.00 Mn |
| Dec 31, 2025 | -305.00 Mn |
| Sep 30, 2025 | -321.00 Mn |
| Jun 30, 2025 | -104.00 Mn |
| Mar 31, 2025 | -4.14 Bn |
| Dec 31, 2024 | -303.00 Mn |
| Sep 30, 2024 | -2.17 Bn |
| Jun 30, 2024 | -117.00 Mn |
| Mar 31, 2024 | -408.00 Mn |
| Dec 31, 2023 | -152.00 Mn |
| Sep 30, 2023 | -145.00 Mn |
| Jun 30, 2023 | -533.00 Mn |
| Mar 31, 2023 | -132.00 Mn |
| Dec 31, 2022 | -162.00 Mn |
| Sep 30, 2022 | 72.00 Mn |
| Jun 30, 2022 | -152.00 Mn |
| Mar 31, 2022 | -2.68 Bn |
| Dec 31, 2021 | -314.00 Mn |
| Sep 30, 2021 | -247.00 Mn |